Our Pricing

Cheapest Starting Wegovy at 1.7mg UK: All Five Doses Available

Published on: June 03, 2026

Many patients ask about cheapest starting Wegovy at 1.7mg UK options, particularly when transferring from other treatments or facing dose shortages. At Cured Pharmacy, we stock all five Wegovy doses from £79.00 and our UK clinical team will assess the safest escalation pathway for your individual circumstances, ensuring optimal tolerability and efficacy throughout your weight management programme.

Can You Start Wegovy at 1.7mg Without Dose Escalation?

The licensed Wegovy dosing schedule requires gradual escalation starting at 0.25mg weekly, increasing every four weeks through 0.5mg, 1mg, and 1.7mg, before reaching the maintenance dose of 2.4mg [1]. This titration schedule is not arbitrary — it significantly reduces gastrointestinal side effects whilst allowing your body to adapt to semaglutide's appetite-suppressing effects.

Starting Wegovy at 1.7mg without prior escalation substantially increases the risk of severe nausea, vomiting, and diarrhoea. In the STEP clinical trials, participants who followed the gradual dose escalation experienced notably fewer treatment discontinuations due to adverse effects compared to those given higher initial doses [1][2]. The MHRA-approved product information explicitly recommends the four-week escalation protocol for this reason. For the cheapest starting Wegovy at 1.7mg UK service with full clinical oversight, Cured Pharmacy is your trusted option.

However, patients transferring from Ozempic 1mg (the same active ingredient, semaglutide) may be suitable for a modified escalation pathway. Your UK prescriber will evaluate your treatment history, tolerance to previous doses, and individual risk factors before determining the appropriate starting dose. This clinical assessment is mandatory for all prescription weight loss treatments dispensed by Cured Pharmacy.

Why Wegovy Dose Escalation Matters for Treatment Success

The gradual dose escalation protocol serves two critical purposes: minimising gastrointestinal side effects and optimising long-term adherence. Semaglutide works by slowing gastric emptying and activating GLP-1 receptors in the brain that regulate appetite [2]. When introduced too rapidly, these mechanisms can overwhelm your digestive system, causing debilitating nausea that leads many patients to discontinue treatment prematurely.

Clinical data from the STEP programme demonstrated that participants following the standard escalation schedule achieved an average 14.9% body weight reduction over 68 weeks, with treatment completion rates exceeding 80% [2]. Conversely, studies examining accelerated dose escalation showed discontinuation rates nearly double those of the standard protocol, primarily due to gastrointestinal intolerance.

Each four-week period at a lower dose allows your body to adapt physiologically. Your stomach gradually adjusts to slower emptying, nausea receptors become less sensitive, and appetite regulation normalises without the shock of sudden, dramatic suppression. This biological adaptation period is essential for sustainable weight loss and explains why the MHRA licensing specifically mandates the escalation schedule.

What Happens If You Skip Dose Escalation

Supply chain disruptions have plagued weight loss treatments across the UK, with many pharmacies unable to stock the complete Wegovy dose range. This creates dangerous gaps in treatment continuity — patients forced to skip doses or switch medications abruptly face both reduced efficacy and increased side effects. At Cured Pharmacy, we maintain stock of all five Wegovy doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) to ensure uninterrupted treatment progression, offering the cheapest starting Wegovy at 1.7mg UK pricing available.

Our clinical team at Cured Pharmacy has observed that patients who respect the escalation schedule not only tolerate treatment better but also achieve superior long-term weight loss outcomes. The temporary patience required during the initial 16 weeks of escalation translates to sustained adherence and results over the following months and years.

All Five Wegovy Doses Available at Cured Pharmacy

Supply chain disruptions have plagued weight loss treatments across the UK, with many pharmacies unable to stock the complete Wegovy dose range. This creates dangerous gaps in treatment continuity — patients forced to skip doses or switch medications abruptly face both reduced efficacy and increased side effects. At Cured Pharmacy, we maintain stock of all five Wegovy doses (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) to ensure uninterrupted treatment progression.

The ordering process takes under three minutes. You'll complete a confidential online consultation reviewed by a UK-registered prescriber, who will determine your suitability for Wegovy and prescribe the appropriate starting dose based on your medical history. If approved, your prescription is sent to our dispensing team and your medication ships in 100% discreet packaging with next-day delivery options available. This makes us the go-to choice for cheapest starting Wegovy at 1.7mg UK patients.

Every Wegovy pen dispensed by Cured Pharmacy is sourced directly from UK-licensed wholesalers and carries full MHRA regulatory approval. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees our supply chain to guarantee authenticity and proper cold-chain storage. You'll receive genuine medication in its original packaging, with batch numbers traceable to the manufacturer.

How to Order All Wegovy Doses from Cured Pharmacy

The ordering process takes under three minutes. You'll complete a confidential online consultation reviewed by a UK-registered prescriber, who will determine your suitability for Wegovy and prescribe the appropriate starting dose based on your medical history. If approved, your prescription is sent to our dispensing team and your medication ships in 100% discreet packaging with next-day delivery options available.

Our clinical team provides ongoing support throughout your dose escalation journey. If you experience side effects or have questions about progressing to the next dose, you can contact our pharmacists directly on (+44) 116 4646009. This continuity of care ensures you're never navigating treatment challenges alone, unlike one-off prescription services that disappear after the initial consultation.

Transferring to Wegovy 1.7mg from Other Semaglutide Treatments

Patients currently taking Ozempic 1mg for weight management may be suitable candidates for transferring directly to Wegovy 1.7mg, bypassing the lower escalation doses. Because both medications contain semaglutide at comparable therapeutic levels, your body has already adapted to the GLP-1 mechanism, reducing the risk of gastrointestinal intolerance when stepping up to 1.7mg.

However, this transfer requires careful clinical evaluation. Your UK prescriber will assess how long you've been on Ozempic 1mg, your tolerance history, any previous dose-related side effects, and your weight loss response. Some patients benefit from a brief period at Wegovy 1mg before progressing to 1.7mg, particularly if they experienced nausea during their initial Ozempic escalation.

It's important to note that Ozempic is licensed for type 2 diabetes management, whilst Wegovy is specifically licensed for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities [1]. Transferring from Ozempic to Wegovy ensures you're receiving treatment under the correct regulatory indication, which matters for insurance documentation and clinical governance.

Managing Side Effects During Wegovy Dose Escalation

Even with proper dose escalation, some patients experience gastrointestinal side effects, particularly during the first few days after each dose increase. Nausea is the most commonly reported adverse effect, occurring in approximately 44% of participants in the STEP trials, though severity typically diminishes within 3-5 days as your body adjusts [2].

Practical management strategies significantly improve tolerability. Eating smaller, more frequent meals rather than three large portions reduces gastric distension. Avoiding high-fat foods, which delay gastric emptying further, minimises nausea triggers. Staying well-hydrated and avoiding lying down immediately after eating also helps. If nausea persists beyond the first week at a new dose, contact your prescriber — you may benefit from remaining at your current dose for an additional four weeks before escalating.

Constipation affects roughly 24% of Wegovy users and results from slowed gastrointestinal motility [2]. Increasing dietary fibre through vegetables, fruits, and whole grains, combined with adequate water intake (at least 2 litres daily), usually resolves this. Over-the-counter fibre supplements or gentle laxatives can be used short-term if needed, though always inform your pharmacist of any additional medications you're taking to check for interactions.

When to Contact Your Prescriber

Whilst 2.4mg is the licensed maintenance dose for Wegovy, the 1.7mg dose represents a clinically effective alternative for patients who cannot tolerate the highest dose or who achieve satisfactory weight loss outcomes at the lower level. In the STEP trials, participants at 1.7mg still demonstrated substantial weight reduction, averaging approximately 12-13% body weight loss over 68 weeks [2]. Cured Pharmacy offers the cheapest starting Wegovy at 1.7mg UK pricing for those remaining on this maintenance dose.

Our clinical team at Cured Pharmacy provides ongoing support throughout your treatment. You're not simply handed a prescription and left to manage alone — you have direct access to UK-registered pharmacists who understand semaglutide's side effect profile and can provide evidence-based guidance tailored to your specific circumstances.

Wegovy 1.7mg vs 2.4mg: Understanding Maintenance Doses

Whilst 2.4mg is the licensed maintenance dose for Wegovy, the 1.7mg dose represents a clinically effective alternative for patients who cannot tolerate the highest dose or who achieve satisfactory weight loss outcomes at the lower level. In the STEP trials, participants at 1.7mg still demonstrated substantial weight reduction, averaging approximately 12-13% body weight loss over 68 weeks [2].

Your prescriber may recommend remaining at 1.7mg long-term if you experience persistent side effects when attempting 2.4mg, if you've reached your target weight at the lower dose, or if clinical factors such as age or concurrent medications suggest a more conservative approach. There's no clinical requirement to reach 2.4mg if 1.7mg is delivering the therapeutic outcomes you need with acceptable tolerability.

Regular monitoring is essential at any maintenance dose. Your prescriber will typically recommend follow-up consultations every 12 weeks to assess weight loss progress, evaluate side effects, review blood pressure and metabolic parameters, and determine whether dose adjustment is appropriate. This ongoing clinical oversight ensures Wegovy remains both safe and effective throughout your treatment journey.

Scientific References

1. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency (MHRA). https://products.mhra.gov.uk/ [accessed 13 August 2026]
2. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
4. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
5. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy (semaglutide) is a prescription-only medicine licensed for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, alongside a reduced-calorie diet and increased physical activity. Individual results may vary. Side effects can occur; read the patient information leaflet carefully and contact your prescriber if you experience severe or persistent adverse effects.